CORESTEMCHEMON Inc. (KOSDAQ:166480)
1,949.00
+48.00 (2.52%)
At close: Oct 16, 2026
CORESTEMCHEMON Market Cap
CORESTEMCHEMON has a market cap or net worth of 86.46 billion as of October 16, 2026. It is the 28,538th most valuable company in the world and the 1,378th biggest in South Korea. Its market cap has increased by 119.76% in one year.
Market Cap
86.46B
Enterprise Value
119.67B
Revenue
18.29B
Global Rank
Country Rank
#1,378 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since June 26, 2015, CORESTEMCHEMON's market cap has decreased from 653.85B to 86.46B, a decrease of -86.78%. That is a compound annual growth rate of -16.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 86.46B | 5.47% |
| Dec 30, 2025 | 81.98B | -13.27% |
| Dec 30, 2024 | 94.52B | -34.79% |
| Dec 28, 2023 | 144.95B | -43.25% |
| Dec 29, 2022 | 255.40B | -13.00% |
| Dec 30, 2021 | 293.58B | -19.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ViGenCell | 104.75B |
| Y-Biologics | 102.96B |
| AriBioLab | 102.53B |
| Cell Biotech | 101.77B |
| Prestige Biologics | 100.61B |
| BIO-FD&C | 83.04B |
| Choong Ang Vaccine Laboratory | 82.39B |
| EyeGene | 78.94B |